The relationship between pre-procedural elevated arterial lactate and contrast-induced nephropathy following primary percutaneous coronary intervention.

Yang, Jun-Qing; Guo, Xiao-Sheng; Ran, Peng; Hu, Xiang-Ming; Tan, Ning

Yang, Jun-Qing; Guo, Xiao-Sheng; Ran, Peng; Hu, Xiang-Ming; Tan, Ning.

Afiliação

Yang JQ; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Guo XS; Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Ran P; Department of Intensive Care Unit, Zhuhai Golden Bay Center Hospital, Guangdong Provincial People's Hospital Zhuhai Hospital, Zhuhai, China.
Hu XM; Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Tan N; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.

J Thorac Dis ; 13(9): 5467-5476, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34659813

Palavras-chave

Mehran Risk Score (MRS); ST-segment elevated myocardial infarction (STEMI); contrast-induced nephropathy (CIN); lactate; percutaneous coronary intervention (PCI)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article